Local News: Mecklenburg, NY 

 | 

Sign Up

 | 

Sign In

Gilead Sciences News Editors

News Widget

Display the Gilead Sciences news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Gilead Sciences News

News on Gilead Sciences (Ticker: GILD) continually updated from thousands of sources around the net.

3 hrs ago | PR-inside.com

Gilead Sciences, Inc. a " Product Pipeline Review a " H2...

A A A' Product Pipeline Review A A A' H2 2011 - a new company profile report on companiesandmarkets.com Gilead Sciences, Inc.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Startups, Gilead Sciences

20 hrs ago | Seeking Alpha

MFS Investment Management's Top Q4 Undervalued Buys And Sells

Boston-based MFS Investment Management has over $265 billion in assets under management, including over $90 billion in 13-F assets per its latest Q4 filing on Friday.

Comment?

Related Topix: Computers, Office Equipment, Retail, Staples, Biotech, Medicine, Healthcare Industry

Yesterday | Seeking Alpha

Expecting Gilead To Break $70, Outperforming Merck

Since I first promoted Gilead Sciences in my bullish article here , the stock has taken off like a rocket and gained 40.8%, beating the Dow Jones more than 6x over.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Merck , Startups, Gilead Sciences, Merck & Co., Bristol Myers Squibb

Fri Feb 10, 2012

CBS News

Sector Snap: Morgan Stanley on biotech drugmakers

NEW YORK &#8212 A Morgan Stanley analyst said Friday that he believes shares of biotech drugmakers Gilead Sciences, Biogen Idec and Celgene will do well in 2012 because all three companies are poised to report encouraging results for important drug candidates.

Comment?

Related Topix: Biotech, Science / Technology, Investment Banking, Morgan Stanley European Fund, Financial Services, Morgan Stanley, Medicine, Healthcare Industry, Startups, Gilead Sciences

BioSpace

Aptalis Pharmaceutical Technologies Announces FDA Approval of NDA for ...

Aptalis Pharmaceutical Technologies Announces FDA Approval of NDA for Oral Powder Formulation of VireadA , Co-Developed With Gilead Sciences, Inc.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Food and Drug Administration, Viread, Tenofovir (generic), Medication, HIV/AIDS, Health

Seeking Alpha

Analyzing Thursday's Noteworthy Insider Buys And Sells In Healthcare And Tech Sectors

Insiders reported on Thursday that they bought and sold stock in over 350 separate transactions in over 170 different companies.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Startups, Gilead Sciences

Wall St. Cheat Sheet

Traders Analyze Earnings of These 2 Healthcare Stocks

InterMune, Inc. A reported a drop to a loss in the fourth quarter driven by higher costs.A Reported a loss of $44.5 million in the quarter.

Comment?

Related Topix: Biotech, InterMune, Medicine, Healthcare Industry, Financial Markets, Startups, Gilead Sciences, Vertex Pharmaceuticals, Idenix Pharmaceuticals

The Motley Fool

2 Stocks to Beat a Recession

With the Dow well above the 12,000 mark again, but the threat of a recession still present, it would do investors well to consider the impact a renewed downturn might have on our portfolios.

Comment?

Related Topix: Financial Markets, Home, Mortgage, Personal Finance, Annaly Mortgage Management, Real Estate, Biotech, Medicine, Healthcare Industry

Thu Feb 09, 2012

MarketWatch

Biotech Stocks: Can Vertex Pharma shares stage a comeback?

Get news bulletins by email>> China's Jan. trade surplus wider than expected, but exports shrink 0.5% from last year That's a nagging question for investors, who have watched Vertex's once-bright star fade as the shares of rival hepatitis C-drug developers supernovae.

Comment?

Related Topix: Hepatitis, Medicine, Health, Merck & Co., Biotech, Healthcare Industry, Genetics

Freshnews

Gilead Sciences to Present at Two Upcoming Investor Conferences

FOSTER CITY, Calif. -- -- Gilead Sciences, Inc. today announced that John F. Milligan, PhD, Gilead's President and Chief Operating Officer, will be participating in "fireside chat" forums at two upcoming investor conferences taking place in New York.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Startups, Gilead Sciences, Foster City, CA

San Diego Reader

UCSD Announces Alumni Honorees

UC San Diego has released the names of five alumni and supporters of the university to be honored at its annual Alumni Celebration on June 2 as part of its Alumni Weekend from Mary 31 through June 3. Dr.

Comment?

Related Topix: UC San Diego, Biotech, Medicine, Healthcare Industry, Inventions, Science / Technology

Wall St. Cheat Sheet

Healthcare Stocks in Trading Spotlight Before Earnings

InterMune, Inc. A will unveil its latest earnings on Thursday, February 9, 2012.A The average estimate of analysts is for a loss of 71 cents per share, a wider loss from the year earlier quarter net loss of 39 cents.

Comment?

Related Topix: Biotech, InterMune, Medicine, Healthcare Industry, Financial Markets, Startups, Gilead Sciences, Vertex Pharmaceuticals, Idenix Pharmaceuticals

Investopedia

Big Bets on High-Flying Pharma Stock

Following bullish earnings, Karee Venema of Schaeffer's Research writes that call buyers are piling in to one biopharmaceutical stock that has soared to three-year highs in just the last 60 days.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Startups, Gilead Sciences

Wed Feb 08, 2012

BusinessWeek

Gilead Rises on Hepatitis C Trial Results: San Francisco Mover

Gilead Sciences Inc., the drugmaker that acquired Pharmasset Inc. last month for its experimental hepatitis C treatments, gained the most in three years after one of the medicines produced positive clinical trial results.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Startups, Gilead Sciences, Pharmaceuticals, Pharmasset, Foster City, CA, Bristol Myers Squibb

MarketNewsVideo

Wednesday's ETF with Unusual Volume: FBT

The First Trust NYSE Arca Biotechnology Index Fund ETF is seeing unusually high volume in afternoon trading Wednesday, with over 144,000 shares traded versus three month average volume of about 129,000. Shares of FBT were down about 1.2% on the day.

Comment?

Related Topix: Dendreon, Biotech, Medicine, Healthcare Industry, Business News, Video

Tue Feb 07, 2012

UC San Diego

UCSD Alumni Announces 2012 Alumni Honorees

Five distinguished alumni and supporters of the University of California, San Diego will be honored at the university's annual Alumni Celebration to be hosted June 2. This year's scroll of honorees range from a game-changing scientist who has created innovative drugs, to an angel investor who has been the driving force for the Rady School of ... (more)

Comment?

Related Topix: UC San Diego, California, Biotech, Medicine, Healthcare Industry, Inventions, Science / Technology, Marketing

Mon Feb 06, 2012

Wall St. Cheat Sheet

Las Vegas Sands, Mastercard, Gilead, Lockheed Martin Achieve 52-Week Stock Price Highs Today

Las Vegas Sands : After investing his own money to help revive the company, Sheldon Adelson, CEO and chairman of Las Vegas Sands , is reaping the rewards of the casino company's turnaround, says the Wall Street Journal The shares closed at $51.48, down $0.43 or 0.83% on the day.

Comment?

Related Topix: Aerospace-Defense, Biotech, Las Vegas Sands, Gaming, Medicine, Healthcare Industry, Manufacturing, MasterCard, Financial Services, Lockheed Martin, Startups, Gilead Sciences

Seeking Alpha

5 Buying Opportunities Based On Fundamentals, Profitability And Dividends

In the following article I will discuss five companies that are good money making ideas based on fundamentals, profitability and/or dividend payout measurements.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

AmericanBankingNews.com

Gilead Sciences (GILD) Shares Given New $61.00 Price Target by Analyst at ThinkEquity

Equities research analysts at ThinkEquity increased their price target on shares of Gilead Sciences from $50.00 to $61.00 in a research note issued to investors on Monday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Startups, Gilead Sciences, Oppenheimer Holdings, Financial Services, Investment Services, Investment Banking, Jefferies Group

Wall St. Cheat Sheet

Equity Analysis Feb. 6th: Micron Tech, Intel Corp, Gilead, CMS, Diamond Offshore

Micron Technology Inc. : After the death of Micron CEO Steve Appleton, Oppenheimer believes the company has a deep executive bench and several positive catalysts this year.

Comment?

Related Topix: Numonyx, Startups, McAfee, Energy, CMS Energy, Semiconductors, Biotech, Micron Technology, Intel, Medicine, Electronics, Healthcare Industry

Mecklenburg Jobs

Also on Topix